Literature DB >> 29778996

Stent and flow diverter assisted treatment of acutely ruptured brain aneurysms.

José E Cohen1,2, J Moshe Gomori2, Ronen R Leker3, Sergey Spektor1, Hosni Abu El Hassan1, Eyal Itshayek4.   

Abstract

OBJECTIVE: We present our experience with stent techniques in the management of acutely ruptured aneurysms, focusing on aneurysm occlusion rates, intraprocedural complications, and late outcomes.
METHODS: We retrospectively reviewed the clinical records of patients treated by stent techniques during the early acute phase of aneurysmal rupture, from June 2011 to June 2016. Patients who underwent stenting for the management of unruptured aneurysms, or in a delayed fashion for a ruptured lesion, were excluded.
RESULTS: 47 patients met inclusion criteria, including 46 with subarachnoid hemorrhage (SAH). There were 27 men and 20 women, mean age 38 years (range 23-73). They harbored 71 aneurysms, including 56 treated in the acute phase. Aneurysmal dome and neck width averaged 4.7 mm (range 1.7-12.1) and 3.2 mm (range 1.5-7.1), respectively. Single stent techniques were used in 39 patients and dual stent techniques in 17. External ventricular drains (EVDs) were placed before embolization in 35 patients (92%) and after in 3. Intraprocedure thromboembolic complications due to a hyporesponse to antiplatlets in 4 patients (8.5%) were successfully managed with intra-arterial antiplatelet agents. In 45 surviving patients (96%), there was complete aneurysm occlusion at the 9-12 month follow-up in 26/29 aneurysms treated by stent-assisted coiling (90%), in 2/3 aneurysms treated by flow diverter-assisted coiling (66%), and in 19/22 aneurysms treated by flow diverter alone (86%); 42/45 patients (93%) presented with a modified Rankin Scale score of 0-2.
CONCLUSION: Stenting techniques in ruptured aneurysms can be performed with good technical success; however, procedural thromboembolic complications related to the antiplatelet strategy merit investigation. EVD placement before stenting must be considered. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  aneurysm; device; hemorrhage; platelets; subarachnoid

Mesh:

Substances:

Year:  2018        PMID: 29778996     DOI: 10.1136/neurintsurg-2017-013742

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  3 in total

1.  Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms.

Authors:  Edgar A Samaniego; Emilee Gibson; Daichi Nakagawa; Santiago Ortega-Gutierrez; Mario Zanaty; Jorge A Roa; Pascal Jabbour; David M Hasan
Journal:  Stroke Vasc Neurol       Date:  2019-02-03

2.  Stent-assisted coiling of acutely ruptured cerebral aneurysm: a multicenter prospective registry study (SAVE).

Authors:  Gaozhi Li; Yongquan Han; Shenghao Ding; Yaohua Pan; Xiaohua Zhang; Bing Zhao
Journal:  BMC Neurol       Date:  2022-07-18       Impact factor: 2.903

3.  Ventriculostomy-related intracranial hemorrhage following surgical and endovascular treatment of ruptured aneurysms.

Authors:  Moritz Lenschow; Niklas von Spreckelsen; Sergej Telentschak; Christoph Kabbasch; Roland Goldbrunner; Stefan Grau
Journal:  Neurosurg Rev       Date:  2022-04-29       Impact factor: 2.800

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.